Your Patients Need Dexmethylphenidate — And They Need Your Help Finding It

As a prescriber, you know the frustration: you write a prescription for Dexmethylphenidate, and within hours your patient calls back saying the pharmacy doesn't have it. This scenario has become routine during the ongoing ADHD stimulant shortage, and it places a real burden on both patients and clinical staff.

This guide offers a practical, step-by-step approach to helping your patients find Dexmethylphenidate in stock — and what to do when they can't.

Current Availability: What You Should Know

As of early 2026, the Dexmethylphenidate supply situation looks like this:

• Immediate-release (IR) tablets: Generic Dexmethylphenidate IR is generally more available than the XR formulation. Most strengths (2.5 mg, 5 mg, 10 mg) can be found at many pharmacies, though spot shortages occur.
• Extended-release (XR) capsules: Generic Dexmethylphenidate XR remains on the ASHP shortage list. Higher strengths (20 mg, 25 mg, 30 mg, 35 mg, 40 mg) tend to be harder to find than lower strengths (5 mg, 10 mg, 15 mg).
• Brand-name Focalin/Focalin XR: Available from Novartis but cost-prohibitive for many patients ($250–$400+ for Focalin XR without insurance).

For the latest on what's driving these supply issues, see our provider shortage briefing.

Why Patients Can't Find Dexmethylphenidate

Understanding the barriers helps you provide better guidance:

• Pharmacy allocation limits: Chain pharmacies receive controlled substance allocations from distributors based on historical purchasing. During a shortage, these allocations shrink, leaving less supply for patient demand.
• Geographic variation: Availability differs dramatically by region. Urban pharmacies may be more depleted due to higher patient volumes, while suburban and rural locations sometimes have better stock.
• Strength-specific shortages: Manufacturers may prioritize certain strengths over others. A patient on Dexmethylphenidate XR 20 mg may not be able to find that specific strength even when 10 mg capsules are available nearby.
• Prescription transfer restrictions: Schedule II prescriptions cannot be transferred between pharmacies, requiring a new prescription when patients need to try a different location.

What Providers Can Do: 5 Practical Steps

Step 1: Check Availability Before Prescribing

Before sending a prescription to a pharmacy, use Medfinder for Providers or ask the patient to check availability first. This prevents the common cycle of writing a prescription, having the patient go to the pharmacy, discovering it's out of stock, and then needing to rewrite the prescription for a different pharmacy.

A quick availability check at the point of care can save your team and your patient significant time.

Step 2: Write Flexible Prescriptions When Appropriate

Consider strategies that give the pharmacy and patient more options:

• Specify "generic Dexmethylphenidate" rather than brand name to allow the pharmacy to fill with any available generic manufacturer.
• Consider prescribing available strengths: If 20 mg XR is unavailable, two 10 mg XR capsules may achieve the same result (confirm with your clinical judgment).
• Have a backup formulation ready: If XR is unavailable, an IR prescription with appropriate twice-daily dosing can serve as a bridge.

Step 3: Send Prescriptions Electronically to Confirmed-Stock Pharmacies

Once you or the patient identifies a pharmacy with stock via Medfinder, send the e-prescription directly to that location. This is faster and more reliable than having the patient carry a paper prescription to multiple pharmacies.

Step 4: Maintain a Conversion Reference

Keep dose-conversion information readily accessible for your clinical team:

• Dexmethylphenidate → Methylphenidate: Multiply Dexmethylphenidate dose by 2 (e.g., Dexmethylphenidate 10 mg ≈ Methylphenidate 20 mg)
• Dexmethylphenidate XR → Dexmethylphenidate IR: Same total daily dose, split into two doses at least 4 hours apart
• Dexmethylphenidate → Amphetamines: No direct conversion; start at a conservative amphetamine dose and titrate

Step 5: Proactively Discuss Alternatives With At-Risk Patients

For patients who have experienced repeated fill failures, initiate the alternatives conversation before they run out. Options include:

• Methylphenidate (Ritalin, Concerta, Ritalin LA): Most pharmacologically similar option
• Amphetamine/Dextroamphetamine (Adderall, Adderall XR): Different mechanism, widely prescribed
• Lisdexamfetamine (Vyvanse): Prodrug with lower abuse potential; generic available
• Atomoxetine (Strattera): Non-stimulant; not subject to Schedule II supply constraints

Refer patients to our alternatives guide for additional context they can review between visits.

Alternatives at a Glance

Here's a quick reference table for the most common alternatives:

• Methylphenidate ER (Concerta): 18 mg, 27 mg, 36 mg, 54 mg — once daily. Most direct pharmacologic equivalent.
• Methylphenidate IR (Ritalin): 5 mg, 10 mg, 20 mg — twice or three times daily. Widely available generic.
• Mixed Amphetamine Salts (Adderall XR): 5–30 mg — once daily. Different drug class; requires new titration.
• Lisdexamfetamine (Vyvanse): 10–70 mg — once daily. Prodrug; generic available since 2023.
• Atomoxetine (Strattera): 10–100 mg — once or twice daily. Non-stimulant; takes 4–6 weeks for full effect.

Workflow Tips for Managing the Shortage

Integrate these practices into your clinical workflow to reduce the burden on your team:

• Designate a staff member to handle shortage-related pharmacy calls and prior authorizations.
• Create template messages for patients explaining the shortage and providing self-help resources (including links to Medfinder and finding Dexmethylphenidate in stock).
• Document shortage-related changes in the EHR so that any provider reviewing the chart understands why a medication was changed.
• Set patient expectations during visits: explain that the shortage is ongoing and encourage patients to begin searching for their medication as soon as they receive the prescription.
• Review patients at regular intervals rather than waiting for emergency calls about unfilled prescriptions.

Cost Resources to Share With Patients

Many patients face cost barriers on top of availability issues. Point them toward:

• Discount cards: SingleCare and GoodRx can bring generic Dexmethylphenidate IR down to ~$19 for 30 tablets
• Novartis copay card: Covers up to $60/month for commercially insured patients on brand Focalin XR
• Novartis Patient Assistance Foundation: Free medication for eligible uninsured patients
• Full cost guide: How to Help Patients Save Money on Dexmethylphenidate

Final Thoughts

The Dexmethylphenidate shortage requires providers to be more flexible, more communicative, and more proactive than usual. By checking availability before prescribing, maintaining conversion references, and connecting patients with tools like Medfinder for Providers, you can significantly reduce the burden on your patients and your practice.

The shortage is gradually improving, but it's not over. Stay informed, stay flexible, and keep your patients' access to ADHD treatment a priority.